Publikationen

Wilke T, Mueller S, Groth A, Berg B, Fuchs A, Sikirica M, Logie J, Martin A, Maywald U. nbsp] Non Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis. Diabetes Research. March 2016, Volume 7, Issue 1, pp 105-124

Wilke T. · Böttger B. · Berg B. · Groth A. · Botteman M. · Yu S. · Fuchs A. · Maywald U.   Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients  Nephron 2016;132:215-226 (DOI:10.1159/000444420)

Mueller S, Agostini H, Ehlken Ch, Bauer-Steinhusen U, Hasanbasic Z, Wilke T.  Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration. Ophthalmology.DOI:http://dx.doi.org/10.1016/j.ophtha.2015.12.001

Böttger B, Thate-Waschke IM,Bauersachs R, Kohlmann T, Wilke T.  Preferences for anticoagulation therapy in aterial fibrilllation: the patients´view. Journal of Thrombosis and Thrombolysis. 2015 Nov; 40(4):406-415

Wilke T, Böttger B, Berg B, Groth A, Müller S, Botteman m, Yu S, Fuchs A, Maywald A.  Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients. Journal of Diabetes and its Complications. 2015, Volume 29 (8): 1015–1023

Groth A, Halder F, Fuchs A, Maywald U, Wilke T. Unterversorgung von Vorhofflimmer-Patienten mit oralen Antikoagulanzien in Deutschland. Der Kardiologe. 2015 Okt, 9(5):379-392

Wilke T, Mueller S, Groth A, Fuchs A, Seitz L, Kienhöfer J, Maywald U, Lundershausen R, Wehling M. Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2015 Feb 3;14(1):14.

Müller S, Wilke T. Validation of the Adherence Barriers Questionnaire (ABQ) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence. Value in Health. 2014;17(7):A512.

Wilke T, Groth A, Berg B, Sikirica M, Martin AA, Fuchs A, Maywald U. Non-Adherence And Non-Persistence Related To Glp-1 Therapy In Patients With Diabetes Mellitus Type 2 (T2dm): Analysis of A Large German Claims-Based Dataset And Comparison To Oral Anti-Diabetics. Value in Health. 2014;17(7):A359.

Böttger B, Thate-Waschke IM, Bauersachs R, Kohlmann T, Wilke T. Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment. Value in Health. 2014;17(7):A495.